EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc. (OTCBB: FCSC), a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced today that David M. Pernock, the Company’s Chairman and CEO, will be presenting at the Maxim Group Growth Conference to be held on Thursday, November 18, 2010, at The Grand Hyatt Hotel in New York.
